Literature DB >> 31813737

The Disease Ecology, Epidemiology, Clinical Manifestations, and Management of Emerging Cryptococcus gattii Complex Infections.

James H Diaz1.   

Abstract

Cryptococcus neoformans, a soil-dwelling fungus found worldwide, can cause cryptococcosis, an opportunistic fungal infection of the lungs and central nervous system. One former member of the C neoformans complex, Cryptococcus gattii, has caused meningitis in immunosuppressed and immunocompetent persons in endemic regions in Africa and Asia. Between 1999 and 2004, C gattii caused outbreaks of human cryptococcosis in unexpected, nonendemic, nontropical regions on Vancouver Island, Canada, and throughout the US Pacific Northwest and California. C gattii was recognized as an emerging species with several genotypes and a unique environmental relationship with trees that are often encountered in the wilderness and in landscaped parks. Because C gattii infections have a high case-fatality rate, wilderness medicine clinicians should be aware of this emerging pathogen, its disease ecology and risk factors, its expanding geographic distribution in North America, and its ability to cause fatal disease in both immunosuppressed and immunocompetent persons.
Copyright © 2019 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cryptococcomas; cryptococcosis

Year:  2019        PMID: 31813737     DOI: 10.1016/j.wem.2019.10.004

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  9 in total

1.  Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling.

Authors:  Tyler G Normile; Timothy H Chu; Brian S Sheridan; Maurizio Del Poeta
Journal:  Mucosal Immunol       Date:  2022-10-13       Impact factor: 8.701

2.  Subcutaneous Mycoses in Travelers.

Authors:  Andrés Tirado-Sánchez; Carlos Franco-Paredes; Alexandro Bonifaz
Journal:  Curr Trop Med Rep       Date:  2020-11-06

3.  Global warming impact on the expansion of fundamental niche of Cryptococcus gattii VGI in Europe.

Authors:  Massimo Cogliati
Journal:  Environ Microbiol Rep       Date:  2021-05-04       Impact factor: 3.541

Review 4.  Climate Change and Infections on the Move in North America.

Authors:  Naomi Hauser; Kathryn C Conlon; Angel Desai; Leda N Kobziar
Journal:  Infect Drug Resist       Date:  2021-12-30       Impact factor: 4.003

5.  Pulmonary cryptococcosis misdiagnosed as lung cancer in a man with normal immune function: A case report.

Authors:  Shixiang Qiu; Chao Chen; Ya Li; Chao Li; Ziyu Tang; Yunguo Liao; Dan Deng; Liming Zhong
Journal:  Radiol Case Rep       Date:  2022-02-04

6.  The Sweet Side of Fungal Infections: Structural Glycan Diversity and Its Importance for Pathogenic Adaptation.

Authors:  Israel Diniz-Lima; Leonardo Marques da Fonseca; Jhenifer Santos Dos Reis; Marcos André Rodrigues da Costa Santos; Kelli Monteiro da Costa; Carlos Antonio do Nascimento Santos; Pedro Marçal Barcelos; Kamila Guimarães-Pinto; Alessandra Almeida Filardy; Marco Edilson Freire-de-Lima; Debora Decote-Ricardo; Alexandre Morrot; Celio Geraldo Freire-de-Lima; Leonardo Freire-de-Lima
Journal:  Medicines (Basel)       Date:  2022-06-16

7.  Liposomal Ellagic Acid Alleviates Cyclophosphamide-Induced Toxicity and Eliminates the Systemic Cryptococcus neoformans Infection in Leukopenic Mice.

Authors:  Masood Alam Khan; Arif Khan; Mohd Azam; Khaled S Allemailem; Faris Alrumaihi; Ahmad Almatroudi; Fahad A Alhumaydhi; Faizul Azam; Shaheer Hasan Khan; Syeda Fauzia Farheen Zofair; Sumbul Ahmad; Hina Younus
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

8.  Disseminated cryptococcosis in an immunocompetent patient.

Authors:  Rahul Bollam; Mohamed Yassin; Tung Phan
Journal:  Respir Med Case Rep       Date:  2020-03-03

Review 9.  The interplay of phenotype and genotype in Cryptococcus neoformans disease.

Authors:  Sophie Altamirano; Katrina M Jackson; Kirsten Nielsen
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.